IN2014MN00949A - - Google Patents
Info
- Publication number
- IN2014MN00949A IN2014MN00949A IN949MUN2014A IN2014MN00949A IN 2014MN00949 A IN2014MN00949 A IN 2014MN00949A IN 949MUN2014 A IN949MUN2014 A IN 949MUN2014A IN 2014MN00949 A IN2014MN00949 A IN 2014MN00949A
- Authority
- IN
- India
- Prior art keywords
- interleukin
- chain
- relates
- coagulation factor
- factor xiii
- Prior art date
Links
- 206010061481 Renal injury Diseases 0.000 abstract 3
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 abstract 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
- 102000004411 Antithrombin III Human genes 0.000 abstract 1
- 108090000935 Antithrombin III Proteins 0.000 abstract 1
- 102000019401 Coagulation factor XIII A chains Human genes 0.000 abstract 1
- 108050006954 Coagulation factor XIII A chains Proteins 0.000 abstract 1
- 102100029058 Coagulation factor XIII B chain Human genes 0.000 abstract 1
- 101710142646 Coagulation factor XIII B chain Proteins 0.000 abstract 1
- 102100031758 Extracellular matrix protein 1 Human genes 0.000 abstract 1
- 101710127949 Extracellular matrix protein 1 Proteins 0.000 abstract 1
- 102100040896 Growth/differentiation factor 15 Human genes 0.000 abstract 1
- 101710194460 Growth/differentiation factor 15 Proteins 0.000 abstract 1
- 102000013691 Interleukin-17 Human genes 0.000 abstract 1
- 108050003558 Interleukin-17 Proteins 0.000 abstract 1
- 102100030703 Interleukin-22 Human genes 0.000 abstract 1
- 101710180553 Proprotein convertase subtilisin/kexin type 9 Proteins 0.000 abstract 1
- 102100038955 Proprotein convertase subtilisin/kexin type 9 Human genes 0.000 abstract 1
- 102100030511 Stanniocalcin-1 Human genes 0.000 abstract 1
- 101710142157 Stanniocalcin-1 Proteins 0.000 abstract 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 abstract 1
- 102000008228 Toll-like receptor 2 Human genes 0.000 abstract 1
- 108010060888 Toll-like receptor 2 Proteins 0.000 abstract 1
- 108010031318 Vitronectin Proteins 0.000 abstract 1
- 102100035140 Vitronectin Human genes 0.000 abstract 1
- 229960005348 antithrombin iii Drugs 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000000104 diagnostic biomarker Substances 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- 229930182833 estradiol Natural products 0.000 abstract 1
- 108010074109 interleukin-22 Proteins 0.000 abstract 1
- 208000037806 kidney injury Diseases 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 229960003387 progesterone Drugs 0.000 abstract 1
- 239000000186 progesterone Substances 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 239000000092 prognostic biomarker Substances 0.000 abstract 1
- 229940034208 thyroxine Drugs 0.000 abstract 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161562824P | 2011-11-22 | 2011-11-22 | |
| US201161562813P | 2011-11-22 | 2011-11-22 | |
| US201161562872P | 2011-11-22 | 2011-11-22 | |
| US201161562947P | 2011-11-22 | 2011-11-22 | |
| US201161562916P | 2011-11-22 | 2011-11-22 | |
| US201161562951P | 2011-11-22 | 2011-11-22 | |
| US201161562879P | 2011-11-22 | 2011-11-22 | |
| US201161562829P | 2011-11-22 | 2011-11-22 | |
| US201161562885P | 2011-11-22 | 2011-11-22 | |
| US201161562883P | 2011-11-22 | 2011-11-22 | |
| US201161562817P | 2011-11-22 | 2011-11-22 | |
| US201161562943P | 2011-11-22 | 2011-11-22 | |
| US201161562802P | 2011-11-22 | 2011-11-22 | |
| US201161562778P | 2011-11-22 | 2011-11-22 | |
| PCT/US2012/066152 WO2013078253A1 (en) | 2011-11-22 | 2012-11-20 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00949A true IN2014MN00949A (enExample) | 2015-04-24 |
Family
ID=48470273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN949MUN2014 IN2014MN00949A (enExample) | 2011-11-22 | 2012-11-20 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20140315752A1 (enExample) |
| EP (2) | EP2783213B1 (enExample) |
| AU (1) | AU2012340748A1 (enExample) |
| CA (1) | CA2856399A1 (enExample) |
| IN (1) | IN2014MN00949A (enExample) |
| WO (1) | WO2013078253A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150017671A1 (en) | 2004-04-16 | 2015-01-15 | Yaping Shou | Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity |
| HK1222455A1 (zh) * | 2013-06-05 | 2017-06-30 | 阿斯图特医药公司 | 用於肾损伤和肾衰竭的诊断及预後的方法和组合物 |
| US20160282344A1 (en) * | 2013-11-15 | 2016-09-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of sepsis |
| EP3922259A1 (en) * | 2014-10-30 | 2021-12-15 | Acceleron Pharma Inc. | Methods and compositions using gdf15 polypeptides for increasing red blood cells |
| WO2016123163A2 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
| WO2021130138A1 (en) | 2019-12-23 | 2021-07-01 | Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol (Igtp) | New protein markers of renal damage |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (en) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| JPH06506688A (ja) | 1991-04-10 | 1994-07-28 | バイオサイト・ダイアグノスティックス・インコーポレイテッド | クロストークインヒビターおよびその使用 |
| FI934438L (fi) | 1991-04-12 | 1993-11-04 | Biosite Diagnostics Inc | Nya konjugater och foerfaranden foer samtidig detektering av flera ligander |
| US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| US20040009171A1 (en) * | 2001-10-18 | 2004-01-15 | Genentech, Inc. | Methods for the treatment of carcinoma |
| WO2006083986A2 (en) * | 2005-02-01 | 2006-08-10 | Government Of The U.S.A, As Represented By The Secretary Department Of Health & Human Services | Biomarkers for tissue status |
| EP2500723B1 (en) * | 2006-11-14 | 2015-07-08 | Alere San Diego, Inc. | Methods for monitoring and risk prediction in cardiorenal syndrome |
| US8221995B2 (en) * | 2007-03-23 | 2012-07-17 | Seok-Won Lee | Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| CN105067819B (zh) * | 2008-08-28 | 2018-05-22 | 阿斯图特医药公司 | 用于诊断和预后肾损伤和肾衰竭的方法和组合物 |
| EP2350669B9 (en) * | 2008-10-31 | 2014-06-11 | St Vincent's Hospital Sydney Limited | Methods of prognosis in chronic kidney disease |
| EP3246708A3 (en) * | 2009-12-18 | 2018-01-03 | Roche Diagnostics GmbH | Troponins for predicting kidney failure in heart surgery patients |
| NZ600828A (en) * | 2009-12-20 | 2014-09-26 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
-
2012
- 2012-11-20 IN IN949MUN2014 patent/IN2014MN00949A/en unknown
- 2012-11-20 WO PCT/US2012/066152 patent/WO2013078253A1/en not_active Ceased
- 2012-11-20 CA CA2856399A patent/CA2856399A1/en not_active Abandoned
- 2012-11-20 EP EP12851561.6A patent/EP2783213B1/en not_active Not-in-force
- 2012-11-20 EP EP17190074.9A patent/EP3282257A1/en not_active Withdrawn
- 2012-11-20 AU AU2012340748A patent/AU2012340748A1/en not_active Abandoned
- 2012-11-20 US US14/359,910 patent/US20140315752A1/en not_active Abandoned
-
2017
- 2017-07-26 US US15/660,875 patent/US20170336421A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013078253A1 (en) | 2013-05-30 |
| CA2856399A1 (en) | 2013-05-30 |
| EP2783213A4 (en) | 2015-09-09 |
| EP2783213B1 (en) | 2017-09-13 |
| US20140315752A1 (en) | 2014-10-23 |
| EP2783213A1 (en) | 2014-10-01 |
| EP3282257A1 (en) | 2018-02-14 |
| NZ625725A (en) | 2016-09-30 |
| AU2012340748A1 (en) | 2014-06-26 |
| US20170336421A1 (en) | 2017-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN00949A (enExample) | ||
| MX341191B (es) | Metodos y composiciones para diagnostico y prognosis de lesion renal y falla renal. | |
| MX2011004767A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. | |
| NZ630277A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP1996940A4 (en) | DETECTION OF CANCER DUE TO INCREASED BCL-2 CONCENTRATIONS | |
| NZ701807A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| NZ592552A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| PH12014500650A1 (en) | Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage | |
| DE602007007209D1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
| NZ593514A (en) | p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer | |
| MX2011008323A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. | |
| EP2585826A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE | |
| NZ608316A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EP2569635A4 (en) | METHOD FOR DIAGNOSIS AND / OR TREATMENT OF ENZEPHALITIS OR EPILEPSY | |
| MX2012003168A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal. | |
| PE20120592A1 (es) | Metodo con biomarcadores para el seguimiento de un tratamiento | |
| WO2006092729A3 (en) | Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals | |
| ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs | |
| ATE353544T1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome | |
| IN2014MN01759A (enExample) | ||
| NZ703055A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| ATE359516T1 (de) | Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs | |
| ATE443871T1 (de) | Test zum nachweis von pathologischen prionen | |
| DE602004013355D1 (de) | Verwendung des proteins spee als marker für brustkrebs | |
| WO2012103450A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |